Medicines Australia welcomes the announcement of a review of the PBAC Guidelines.

“We are pleased that the Government has announced that a review of the PBAC Guidelines will be undertaken,” Medicines Australia CEO, Tim James, said.

“Any opportunity that we can have to improve the quality of our health technology system in Australia must be taken, for Australia to keep pace with the rest of the world.”

The volume and depth of information provided by pharmaceutical companies to the PBAC in health technology submissions is large and growing. As new technologies are developed and drug discovery and research becomes more complex and targeted to specific genetic variations, it is critical to continuously review the guidelines that underpin the system.

“Medicines Australia is committed to good, high quality health technology assessment in Australia and is always ready to work with the government to ensure this is achieved,” Mr James said.

For more details, go to: https://medicinesaustralia.com.au/media-release/pbac-guidelines-review-welcomed/